June Morris Biography and Net Worth

Insider of Vicarious Surgical

Prior to joining Vicarious Surgical, Mr. Kelly served as Chief Financial Officer at Exosome Diagnostics, a privately held healthcare company focused on developing and commercializing revolutionary biofluid-based diagnostics, from 2014 to 2018. During his time at Exosome Diagnostics, he helped raise over $60 million and oversaw its transition to a commercial stage company with the successful launch of its first product, Exosome Prostate Intelliscore. In 2018, Mr. Kelly managed the negotiation and execution of the company's sale to Bio-Techne, Inc. for $575 million, including contingent.

Before joining Exosome Diagnostics, Inc., Mr. Kelly served as Chief Financial Officer of Repligen Corporation, a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems. While at Repligen Corporation, Mr. Kelly was responsible for all aspects of Repligen's finance, human resources, information technology and facilities operations and helped lead the company through its transition to a commercial bioprocessing enterprise driving growth of nearly ten times in market capitalization.

What is June Morris' net worth?: The estimated net worth of June Morris is at least $234,968.85 as of September 20th, 2023. Ms. Morris owns 19,339 shares of Vicarious Surgical stock worth more than $234,969 as of December 24th. This net worth approximation does not reflect any other investments that Ms. Morris may own. Learn More about June Morris' net worth.
How do I contact June Morris?: The corporate mailing address for Ms. Morris and other Vicarious Surgical executives is 78 Fourth Avenue Waltham, MA 02451. Vicarious Surgical can also be reached via phone at 617 868 1700 and via email at [email protected]. Learn More on June Morris' contact information.
Has June Morris been buying or selling shares of Vicarious Surgical?: June Morris has not been actively trading shares of Vicarious Surgical in the last ninety days. Most recently, June Morris sold 36 shares of the business's stock in a transaction on Wednesday, September 20th. The shares were sold at an average price of $23.70, for a transaction totalling $853.20. Following the completion of the sale, the insider now directly owns 19,339 shares of the company's stock, valued at $458,334.30. Learn More on June Morris' trading history.
Who are Vicarious Surgical's active insiders?: Vicarious Surgical's insider roster includes Sammy Khalifa (CTO), June Morris (Insider), and Adam Sachs (CEO). Learn More on Vicarious Surgical's active insiders.
Are insiders buying or selling shares of Vicarious Surgical?: During the last year, insiders at the sold shares 33 times. They sold a total of 10,665 shares worth more than $102,318.18. The most recent insider tranaction occured on December, 3rd when CFO William John Kelly sold 218 shares worth more than $2,923.38. Insiders at Vicarious Surgical own 11.7% of the company. Learn More about insider trades at Vicarious Surgical.
Information on this page was last updated on 12/3/2024.

June Morris Insider Trading History at Vicarious Surgical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2023	Sell	36	$23.70	$853.20	19,339
9/5/2023	Sell	212	$29.10	$6,169.20	19,375
8/24/2023	Sell	83	$28.50	$2,365.50	19,588
8/21/2023	Sell	213	$27.60	$5,878.80	19,672
6/23/2023	Sell	70	$57.60	$4,032.00	19,885
6/20/2023	Sell	36	$61.50	$2,214.00	19,956
5/24/2023	Sell	83	$69.30	$5,751.90	9,976
5/22/2023	Sell	213	$67.50	$14,377.50	10,060
3/22/2023	Sell	37	$73.80	$2,730.60	10,343
2/24/2023	Sell	83	$84.30	$6,996.90	10,381
2/21/2023	Sell	207	$83.70	$17,325.90	10,464
12/27/2022	Sell	71	$53.10	$3,770.10	10,671
12/20/2022	Sell	35	$56.10	$1,963.50	10,743
11/25/2022	Sell	83	$110.70	$9,188.10	10,778
11/21/2022	Sell	200	$98.40	$19,680.00	10,862
10/24/2022	Sell	83	$94.20	$7,818.60	11,062
9/27/2022	Sell	74	$105.00	$7,770.00	11,146
9/21/2022	Sell	32	$116.70	$3,734.40	11,221
8/29/2022	Sell	45	$114.90	$5,170.50	11,300
8/25/2022	Sell	33	$123.90	$4,088.70	11,369
8/23/2022	Sell	16	$118.80	$1,900.80	11,428
6/27/2022	Sell	75	$108.30	$8,122.50	11,444
6/21/2022	Sell	31	$111.00	$3,441.00	11,520
3/28/2022	Sell	76	$123.30	$9,370.80
1/25/2022	Sell	73	$161.10	$11,760.30

June Morris Buying and Selling Activity at Vicarious Surgical

Vicarious Surgical Company Overview

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $12.15

$11.51

$13.15

50 Day Range

MA: $11.01

$7.04

$16.00

2 Week Range

Now: $12.15

$4.27

$21.43

Volume

14,643 shs

Average Volume

28,254 shs

Market Capitalization

$71.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.